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Abstract
Background: Inflammatory cytokines are detected in the plasma of patients with renal cell carcinoma (RCC) and are
associated with poor prognosis. However, the primary cell type involved in producing inflammatory cytokines and the
biological significance in RCC remain unknown. Inflammation is associated with oxidative stress, upregulation of hypoxia
inducible factor 1-alpha, and production of pro-inflammatory gene products. Solid tumors are often heterogeneous in
oxygen tension together suggesting that hypoxia may play a role in inflammatory processes in RCC. Epithelial cells have
been implicated in cytokine release, although the stimuli to release and molecular mechanisms by which they are released
remain unclear. AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy status and a role for
AMPK in the regulation of cell inflammatory processes has recently been demonstrated.
Methods and Principal Findings: We have identified for the first time that interleukin-6 and interleukin-8 (IL-6 and IL-8) are
secreted solely from RCC cells exposed to hypoxia. Furthermore, we demonstrate that the NADPH oxidase isoform, Nox4,
play a key role in hypoxia-induced IL-6 and IL-8 production in RCC. Finally, we have characterized that enhanced levels of IL-
6 and IL-8 result in RCC cell invasion and that activation of AMPK reduces Nox4 expression, IL-6 and IL-8 production, and
RCC cell invasion.
Conclusions/Significance: Together, our data identify novel mechanisms by which AMPK and Nox4 may be linked to
inflammation-induced RCC metastasis and that pharmacological activation of AMPK and/or antioxidants targeting Nox4
may represent a relevant therapeutic intervention to reduce IL-6- and IL-8-induced inflammation and cell invasion in RCC.
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Introduction
Inflammation is associated with cancer, including renal cell
carcinoma (RCC) [1,2]. Inflammation is caused by a variety of
pathogenic and environmental factors. Various pathogenic and
environmental factors cause inflammation, which involve oxida-
tive stress, upregulation of hypoxia inducible factor 1-alpha, and
production of pro-inflammatory gene products, together suggest-
ing that hypoxia may play a role in inflammatory processes in
RCC [3]. Cytokines have been detected in the plasma of patients
with advanced renal cancer and is associated with poor outcomes,
but the source of cytokine production and the biological
significance of cytokine secretion in RCC are not known [4].
Primary cells involved in the release of cytokines include
lymphocytes and macrophages; however, macrophage infiltration
is not a predominant feature of RCC [5]. Epithelial cells have also
been implicated in cytokine release, although the stimuli to release
and molecular mechanisms by which they are released remain
unclear.
Reactive oxygen species (ROS) have been implicated in
inflammatory pathways and cancer through regulation of the
redox state of the target cells. In the kidney, ROS are primarily
produced by NAD(P)H oxidases of the Nox family. Our laboratory
and others has identified Nox oxidases, and particularly the
isoform Nox4, as a major source of ROS in renal cell carcinoma
[6,7,8] and our group has previously demonstrated that AMP-
activated protein kinase (AMPK) is a novel upstream regulator of
Nox oxidase protein expression and activity [9,10,11]. AMPK is a
highly conserved sensor of cellular energy status and a role for
AMPK in the regulation of cell inflammatory processes has
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30712recently been demonstrated [12,13,14]. Pharmacological activa-
tion of AMPK, reduces tumor growth in vitro and in a xenograft
mouse model [15,16], but the role of AMPK in inflammatory
processes in RCC has not been studied.
Metastatic renal cancers are commonly refractory to current
therapy. Molecular identification of signals that elicit RCC
metastasis and the pathways that sense and propagate the response
to invade are lacking. The objectives of this study were to identify
1) renal epithelial-dependent nonpathogen-derived-pro-inflamma-
tory gene products in RCC 2) characterize the microenvironment
and signaling pathways involved in pro-inflammatory release and
3) determine the cellular mechanisms and biological consequences
of cytokine secretion in RCC. Here, we describe a novel interplay
between hypoxia, Nox4 and AMPK that modulates inflammatory
processes in RCC.
Materials and Methods
Materials
N-Acetyl-L-cysteine (NAC, 10mM) and diphenyleneiodonium
chloride (DPI, 5uM) and 5-aminoimidazole-4-carboxamide-1-
riboside (AICAR: 1mM) were purchased from Sigma.
Cell Lines and Cultures
Established (American Type Culture Collection) human renal
proximal tubular cells, HK2; and VHL-deficient cells, RCC 786-
O and RCC4, were maintained in RPMI (HK2) or Dulbecco’s
modified Eagle’s medium (RCC 786-O, RCC4) (DMEM,
Invitrogen) supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 50 units/ml of penicillin and 50 mg/ml streptomycin
sulfate at 37uC with 5% CO2. Ex vivo RCC primary cells were
established from a histologically identified clear cell tumor. The
tumor mass was obtained at the time of tumor resection and
processed under sterile conditions: washed with ice cold PBS,
minced and trypsinized to obtain a single cell suspension and
maintained in DMEM-complete media as used for established
cultured RCC cells. Cells were maintained at 37uC with 5.0%
CO2 and grown to ,65% confluency prior to experimental
procedures.
Western Blotting Analysis
Immunoblotting was performed by running typically between
25–70 mg total protein and incubated with the indicated primary
antibodies: Rabbit polyclonal Nox4 antibody (1:1000) and
GAPDH (1:4000) was purchased from Santa Cruz. Total MAPK
(1:1000), was purchased from cell signaling. The immunoblots
were washed and incubated with Goat anti-rabbit-coupled
horseradish peroxidase (Biorad) followed by chemiluminescence
using ECL reagent (Amersham-Parmacia).
Induction of hypoxia
All cells were cultured in serum-free media ,18 hrs prior to
hypoxia exposure for indicated times. Cultured cells were placed
in a modular incubator chamber (Don Whitley Scientific
Limited, MACS VA500) that was flushed with a gas mixture
(0.5% O2 5.0% CO2 94.5% N2) to remove atmospheric air.
Within 30 minutes, the desired level of hypoxia was achieved.
Samples of media were analyzed for pH at each experimental
time interval (0–48 hours). All buffers and reagents used were
allowed to equilibrate for at least 6 hours in the hypoxic
chamber and hypoxia-induced conditioned media were harvest-
ed or cell lysates prepared in the hypoxic chamber on ice prior to
removal.
Cell viability
Cell viability was determined by trypan blue exclusion. After
hypoxic incubation for 72 h, % cells were assayed for cell viability
using dye exclusion. Live cells with intact cell membranes exclude
trypan blue whereas dead cells do not. Hypoxic cell suspension
was mixed with 0.4% trypan blue in PBS and allowed to sit at
room temperature for 3 minutes and placed in a hemocytometer
and counted under a binocular microscope. The number of
unstained (viable) and stained (nonviable) was counted. All
experiments were carried out in triplicates.
Transfection
A SMARTpool consisting of four short or small interfering
RNAs (siRNA) duplexes specific for human Nox4 was obtained
from Dharmacon. The SMARTpool of siRNA for Nox4 was
transfected using the Amaxa system. Briefly, RCC 786-O cells
were plated in complete medium to obtain 65% confluence on the
day of transfection. 400nM of scrambled control or smart pool
siRNA Nox4 were added to the cells and transfected using the
AMAXA system as to the manufactures specifications. After
transfection, cells were gently plated in complete media overnight
and subjected to serum starvation prior to being placed in the
hypoxic chamber.
ELISA analysis
Established cultured normal proximal tubular epithelial cells
(HK2), VHL-deficient renal carcinoma cells (RCC 786-O and
RCC4), or primary RCC cultured ex vivo cells, were plated on a
100 mm plate, serum starved over night and exposed, or not, to
hypoxia as described above. Inflammatory cytokines were
measured using the Mosaic
TM ELISA (R&D systems) and the
IL-6 and IL-8 ELISA (R&D systems) for specific cytokines. All
assays were preformed as to the manufactures specifications.
In vitro matrigel invasion assays
Invasion of tumor cells were evaluated using a Matrigel coated
modified Boyden chamber (Biocoat
TM Matrigel
TM Invasion
Chamber; Becton Dickinson GmbH, Heidelberg, Germany) as per
manufactures instruction. Briefly, 30,000 were seeded into the
upper well of the chamber containing serum free media. The
lower well contained culture medium containing 10% FBS as a
chemoattractant. After 24 hours the excess cells were wiped away
and the chambers stained for invaded cells. At 24 hrs, the loose
cells on the top of the matrigel membrane were removed with a
cotton swab. The migrated cells were washed with PBS and fixed
with 70% ethanol. Staining was preformed using 0.1% crystal
violet to visualize the migrated cells. The transmigrated cells in the
membrane were counted using a light microscope at 10X
magnification. For each experiment, 10 random high power fields
were photographed, digitalized and counted. In vitro matrigel invasion
using recombinant IL-6 and IL-8. Invasion chambers were prepared as
above. Purified IL-6 (10ng/ml) and IL-8 (15ng/ml) were added at
the indicated concentrations to the top chamber. Results were
recorded as specified. In vitro matrigel invasion using conditioned media.
Invasion chambers were prepared as above. Condition media
from 786-O cells that were exposed to 48 hours of hypoxia, 786-0
cells with a stable Nox4 knock down exposed to 48 hours of
hypoxia and 786–0 cells treated with AICAR and exposed to
48 hours of hypoxia was added to the upper chamber of the
invasion assay. Results were recorded as above. In vitro matrigel
invasion using cultured primary cells. Primary culture cells were
maintained at normoxia and kept in complete media with or
without 24 hour of AICAR pretreatment. These were then added
Nox Oxidase Regulation of IL-6 and IL-8 Production
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collected as above.
Human Tumor Specimens/Ethics Statement
Tumor samples and normal corresponding tissue from patients
with RCC were obtained from the Department of Urology at the
University of Texas Health Science Center at San Antonio under
approved IRB protocol HSC20070777N. This is a ‘‘non-human/
nonresearch’’ protocol, which collects unwanted tissue. The
tumors for this study were histologically classified as clear cell
renal carcinoma and staged according to the TNM classification.
The collection, handling and non-identifiers of human samples
was carried out according to a protocol approved by the
University of Texas Health Science Center at San Antonio,
Institutional Review Board.
Results
Hypoxia-induces interleukin-6 and 8-production solely in
RCC cells
Cytokines have been detected in the plasma of patients with
advanced renal cell carcinoma (RCC) and poor prognosis;
however, macrophage infiltration is not consistently detected in
RCC tumors [4,5]. Tumors are often heterogenous in oxygen
tension [17]. Taken together, we sought to identify the cell type
and stimulus that is responsible for cytokine production in RCC.
Figure 1. Hypoxia induces IL-6 and IL-8 production solely in RCC cells. A) Interleukin-6 (IL-6) and B) Interleukin-8 (IL-8) secretion by normal
proximal tubular epithelial cells (HK2) exposed to normoxic (norm) or hypoxic conditions for short (T15-180min) or long (T24-T72hr) time points was
determined by ELISA. C, D) IL-6 and E, F) IL-8 secretion by renal carcinoma cells (RCC 786-O and RCC4) exposed to normoxic (norm) or hypoxic
conditions for short (T15-180min) or long (T24-T72hr) time points was determined by ELISA as outlined in materials and methods.
doi:10.1371/journal.pone.0030712.g001
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deficient RCC (RCC 786-O and RCC4) cells were subjected to
time controlled normoxic (21% oxygen) or hypoxic (0.5%
oxygen) conditions for short (T159-1809) or long (T24hr-72 hrs)
times. Hypoxic exposure did not alter cell viability or pH in our
studies (data not shown). Cell media was harvested under
normoxic conditions or in the hypoxic chamber. Mosaic Elisa
analysis was conducted for detection of cytokines and interleukins
including, CD40-L, INF-gamma, interleukins- 1A, -1B, -6, -8,
and -17, and TNF-alpha. At normoxic conditions, HK2 cells
expressed minor amounts of interleukins-6 (Fig. 1A) and -8
(Fig. 1B) whereas other cytokines on the panel were barely
detected (data not shown). Importantly, when HK2 cells were
subjected to hypoxic conditions, production of interleukins-6 and
-8 (IL-6 and IL-8) were immediately and significantly reduced.
Even at later time points when levels of IL-6 and IL-8 were
modestly increased, the levels never reached basal starting levels
compared to normoxic conditions. On the other hand, VHL-
deficient RCC cells exposed to normoxic conditions expressed
IL-6 and IL-8 at very low levels (Figs. 1C–F) and unlike HK2
cells, hypoxic conditions resulted in a significant increase of IL-6
and IL-8 production starting at 1809 and steadily increasing to 4–
5 fold by 72 hours (Figs. 1 C–F). Other cytokines tested, CD40-L,
INF-gamma, interleukins- 1A, -1B, -and -17, and TNF-alpha
were not detected under normoxic or hypoxic conditions in RCC
786-O or RCC4 cells (Figs. S1, S2, respectively). Taken together,
these results suggest that RCC cells solely express IL-6 and IL-8
under hypoxic conditions.
Figure 2. Effects of antioxidants on Hypoxia induced IL-6 and IL-8 production in RCC cells. A) Interleukin-6 (IL-6) and B) Interleukin-8 (IL-8)
secretion was measured using ELISA analysis in RCC 786-O cells pretreated for 30 min in buffer alone (-), N-Acetyl-L-cysteine (NAC) or a flavoprotein
inhibitor (DPI) and exposed to normoxic (norm) or hypoxic conditions for 48 hrs. The data were quantitated from three independent experiments and
the results are expressed as the means + S.E. **, p,0.01 versus norm and ##,p ,0.01 versus hypoxic control (-). C) IL-6 and D) IL-8 secretion was
measured using ELISA analysis in RCC 786-O cells transfected with scrambled control (Scr) or small interfering RNA to Nox4 (siNox4) exposed to
normoxic (Norm) or hypoxia for 48 hrs. The data were quantitated from three independent experiments and the results are expressed as the means +
S.E. **, p,0.01 versus norm, #,p ,0.05, and ##,p ,0.01 versus hypoxic scr control. E) RCC 786-O cells transfected with scrambled control (Scr), small
interfering RNA to Nox4 from C, D were analyzed by Western blot with Nox4 antibody or GAPDH control.
doi:10.1371/journal.pone.0030712.g002
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8-production in RCC cells
We next wanted to elucidate the molecular mechanisms by
which hypoxia induces IL-6 and IL-8 production in RCC cells.
Reactive oxygen species (ROS) have been implicated in cytokine
production [18,19]. Our laboratory has previously demonstrated
that VHL-deficient RCC cells demonstrate higher levels of ROS
mediated by Nox oxidases [7,8]. To determine if Nox-dependent
ROS mediate hypoxia-induced IL-6 and IL-8 production, we pre-
incubated RCC 786-O cells with buffer alone (-), the Nox
inhibitor, diphenyleneiodonium (DPI) or the ROS scavenger, N-
Acetyl Cysteine (NAC) for 30 min and subjected to hypoxia or
normoxia for 48 hours. As previously detected, IL-6 and IL-8
production was significantly enhanced at 48 hours (hypoxia (-))
compared to normoxic control. However, RCC cells pre-
incubated with DPI or NAC resulted in a significant reduction
of IL-6 and IL-8 production compared to hypoxic controls (-)
(Figs. 2A and 2B). Together, these data suggest that Nox-
dependent ROS generation are involved in hypoxia-induced IL-
6 and IL-8 production in RCC.
Our laboratory has previously demonstrated that the Nox
catalytic subunit, Nox4 is highly expressed in VHL-deficient RCC
786-O cells and is a major source of oxidative stress in RCC [7].
To determine if Nox4 was involved in hypoxia-induced IL-6 and
IL-8 production, we transfected RCC-786-O cells with small
inhibitory RNAs against Nox4 (siNox4) or scrambled control (scr).
Transfected cells were exposed to hypoxic conditions for 48 hrs.
We found silencing of Nox4 (siNox4) significantly reduced IL-6
and IL-8 production in cells exposed to hypoxic conditions
compared to mock (-) or scrambled control (scr) (Fig. 2C & 2D).
Confirmation of Nox4 knockdown was performed in parallel using
Western blot analysis (Fig. 2E). GAPDH was used as a loading
control. Taken together, our data suggest that Nox4 mediates
hypoxia-induced IL-6 and IL-8 production in RCC cells.
Activation of AMPK reduces Nox4-dependent IL-6 and IL-
8 production under hypoxic conditions
Our group has previously demonstrated that activation of
AMPK using 5-aminoimidazole-4-carboxamide riboside (AI-
CAR), a cell permeable drug that is converted to ZMP, an
analogue of AMP, reduces Nox4 expression and Nox4-dependent
ROS generation [11]. Activation of AMPK has been of recent
clinical interest for the treatment of renal cancer. To determine if
AMPK is an upstream regulator of Nox4 and mediates hypoxia-
induced IL-6 and IL-8 production, we exposed RCC 786-O cells
to normoxic, hypoxic, or pre-incubated RCC cells with the
AMPK activator, AICAR and subjected the cells to hypoxia for
48 hours. As previously noted, IL-6 and IL-8 production was
significantly enhanced at 48 hours (hypoxia (-)) compared to
normoxic control. However, RCC cells pre-incubated with
AICAR resulted in a significant reduction of IL-6 and IL-8
production compared to hypoxic controls (-) (Figs. 3A and 3B).
Importantly, AICAR reduced Nox4 protein expression (Fig. 3C).
GAPDH was used as a loading control.
IL-6 and IL-8 induces RCC cell invasion
Circulating plasma levels of interleukins are associated with
poor prognosis. Renal carcinomas are highly metastatic. To
elucidate the biological significance of IL-6 and IL-8 production in
RCC cells exposed to hypoxia, we examined cell invasion. RCC
786-O cells were plated in a Boyden chamber in the presence of
recombinant IL-6, IL-8 or the combination of IL-6 and IL-8 or
buffer alone (control). We find that incubation of IL-6 alone
increased cell invasion compared to buffer treated media,
Figure 3. Effects of AMPK activation on Hypoxia induced IL-6 and IL-8 production in RCC cells. A) Interleukin-6 (IL-6) and B) Interleukin-8
(IL-8) secretion was measured using ELISA analysis in RCC 786-O cells pretreated for 30 min in buffer alone (-), or the AMPK activator, aminoimidazole-
4-carboxamide-1-riboside 5-aminoimidazole-4-carboxamide-1-riboside (AICAR) and exposed to normoxic (norm) or hypoxic conditions for 48 hrs. The
data were quantitated from three independent experiments and the results are expressed as the means + S.E. **, p,0.01 versus norm, ##,p ,0.01
versus hypoxic control (-). C) Cell lysates were prepared from cells treated with AICAR, (Fig. 3 A, B) and analyzed for Nox4 expression or GAPDH control
by Western blot analysis.
doi:10.1371/journal.pone.0030712.g003
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significant increase of cell migration and addition of IL-6 and IL-8
further increased significant cell migration.
As conditioned medium (CM) from RCC 786-O cells incubated
in hypoxia exhibited high levels of IL-6 and IL-8, which was
reduced by siNox4 and AICAR treatment, we examined the
ability of CM, subjected to the aforementioned conditions, to
induce cell migration. RCC 786-O cells were plated in the Boyden
chamber using CM from RCC 786-O cells exposed to normoxic
or hypoxic conditions for 48 hours. RCC 786-O cells exposed to
hypoxic CM significantly stimulated the migratory activity of RCC
786-O 3 fold compared to normoxic culture conditions (Fig. 4B).
We next tested CM from normoxic or hypoxic RCC 786-O cells
silenced of Nox4 (siNox4) or scrambled control. CM harvested
from hypoxia-induced scrambled transfected cells resulted in a 2.5
fold increase in cell migration compared to normoxic scr control;
whereas CM from hypoxia-induced RCC 786-O cells transfected
with siRNA Nox4 (siNox4) showed a significant reduction in cell
migration compared to hypoxia-induced scr control (Fig. 4C).
Similarly, when CM from RCC 786-O cells exposed to hypoxia in
the presence of AICAR was added to RCC 786-O cells in the
Boyden chamber, hypoxia induced cell migration was reduced
back to basal levels (Fig. 4D). Taken together, this data suggests
that IL-6 and IL-8 mediate cell invasion in RCC cells.
AICAR reduces IL-6, IL-8 and cell invasion in ex-vivo RCC
cells
Activation of AMPK by AICAR reduces Nox4 expression and
production of IL-6 and IL-8 in cultured RCC cells exposed to
hypoxia. Furthermore, independent studies have suggested that
activation of AMPK suppresses proinflammatory responses
[12,13,14]. To determine if AMPK activators are relevant in
clinical specimens, we cultured RCC cells from a human tumor
of clear cell histology and incubated the cells in the presence or
absence of AICAR. Elisa analysis of IL-6 and IL-8 demonstrated
a reduction of IL-6 and IL-8 levels in the ex-vivo RCC cells
exposed to AICAR (Figs. 5A,B). Importantly, cell invasion was
also significantly reduced compared to buffer treated controls
(Fig. 5C).
Figure 4. Effects of IL-6 and IL-8 on RCC cell invasion. A) RCC 786-O cells were treated with recombinant IL-6 and/or IL-8 for 18 hours and cell
invasion was analyzed by Boyden chamber as described in materials and methods. Left panel, the invaded cells were photographed and right panel,
invaded cells were counted and quantified. The graph is representative of ten independent experiments and the results are expressed as the means +
S.E. ***, p,0.001 versus buffer control (-). B) RCC 786-O cells were incubated with condition media from RCC 786-O cells subjected to 48hr norm or
hypoxic conditions (Fig. 1C,E) for 18 hours and cell invasion was analyzed by Boyden chamber. C) RCC 786-O cells were incubated with condition
media from RCC 786-O cells in normoxic media (norm) or hypoxic media from Fig. 2 D, E transfected with scrambled control (scr) or siRNA for Nox4
(siNox4). D) RCC 786-O cells were incubated with condition media from RCC 786-O cells in normoxic media (norm) or hypoxic media from Fig. 3A,B
incubated with buffer control (-) or AICAR. B, C, D, Invaded cells were quantified from three independent experiments and expressed as the means +
S.E. **, p,0.01 versus norm, ##,p ,0.01 versus hypoxic control (-).
doi:10.1371/journal.pone.0030712.g004
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We have identified for the first time that interleukin-6 and
interleukin-8 (IL-6 and IL-8) are secreted solely from RCC cells
exposed to hypoxia. Furthermore, we demonstrate that the
NADPH oxidase isoform, Nox4, play a key role in hypoxia-
induced IL-6 and IL-8 production in RCC. Finally, we have
characterized that enhanced levels of IL-6 and IL-8 result in RCC
cell invasion and that activation of AMPK reduces Nox4
expression, IL-6 and IL-8 production, and RCC cell invasion.
Together, these data identify novel mechanisms by which Nox4
may be linked to inflammation-induced RCC metastasis.
Interleukins have been detected in the serum of patients with
metastatic renal carcinoma; however, the stimulus necessary for
interleukin production and cell type important interleukin
secretion were previously unknown [4,20]. Inflammatory cells,
which normally secrete interleukins, such as macrophages, are not
a predominant feature of RCC [5]. Therefore, we sought other
environmental factors that may be involved. Solid tumors exhibit
intratumor hypoxic states, where regions of low oxygen (hypoxia)
and necrosis are common [17,21]. Importantly, we find that
cultured normal proximal tubular cells exposed to hypoxia
resulted in downregulation of IL-6 and IL-8 production whereas
cultured VHL-deficient RCC cell lines (RCC 786-O and RCC4)
resulted in a significant increase of IL-6 and IL-8 production.
Importantly, we do not find that hypoxia induces significant
changes in cellular pH or cell death under our experimental
conditions (data not shown). Previous studies have demonstrated
enhanced production of IL-6 and IL-8 in various cancer cells such
as pancreatic, ovarian and glioblastoma exposed to hypoxia, but
our study demonstrates for the first time that normal epithelial
cells down-regulate whereas predominantly, renal tumor cells
upregulate interleukin expression under hypoxic conditions
[22,23,24,25]. Additionally, we have identified the signaling
pathways that mediate hypoxia-induced IL-6 and IL-8 production
in RCC cells.
Hypoxia sensing and related signaling events, including
activation of hypoxia-inducible factor 1 (HIF-1), now suggest that
the NADPH oxidase subunit, Nox4, serve as oxygen sensors. For
example, Nox4 is increased by chronic exposure of mice to
hypoxia [26]. Additionally, the human Nox4 promoter harbors a
hypoxia responsive element (HRE) by which HIF-1alpha mediates
rapid Nox4 induction during hypoxia in pulmonary artery
smooth-muscle cells [27]. VHL-deficient RCC 786-O and
RCC4 cells express hypoxia-inducible factors -2 alpha (HIF-
2alpha) and hypoxia-inducible factors 1- and 2- alpha (HIF-
1alpha/HIF-2alpha) respectively. The fact that normal proximal
tubular cells, exposed to hypoxia do not induce interleukin
expression suggests that Nox-dependent production of IL-6 and
IL-8 may not be mediated by hypoxia-inducible factors. In support
of this, we find that incubation of RCC cells with the HIF
inhibitor; 3-(59-hydroxymethyl-29-furyl)-1-benzylindazole (YC-1)
did not block IL-6 and IL-8 production in RCC cells exposed to
hypoxia (data not shown).
We examined other potential upstream regulators of Nox4.
Recently it has been demonstrated that activation of AMPK using
AICAR suppresses pro-inflammatory responses; however, the
biological significance of AMPK activation in hypoxia-induced
Figure 5. Ex-vivo human RCC tumor cells demonstrate reduced cell invasion with AICAR treatment. Human RCC cells were cultured as
described in materials and methods. Freshly prepared ex-vivo cells were incubated with AICAR for 48 hours and A) Interleukin-6 (IL-6) and B)
Interleukin-8 (IL-8) was measured by ELISA analysis. C) Freshly prepared ex-vivo human RCC cells were plated in a Boyden chamber in the presence (+)
or absence (-) of AICAR for 18 hours. Invaded cells were quantified from three independent experiments and expressed as the means + S.E.
***, p,0.001 versus buffer control (-).
doi:10.1371/journal.pone.0030712.g005
Nox Oxidase Regulation of IL-6 and IL-8 Production
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30712interleukin expression and RCC metastasis is unknown. Our
group has previously demonstrated that activation of AMPK down
regulates Nox4 expression and Nox4-dependent apoptosis in renal
podocytes [11]. AMPK is a key nutrient and energy sensor in cells
and in general, AMPK is activated under hypoxic conditions. We
find that AMPK activity is lower in cultured RCC cells compared
to normal renal epithelial cells and that hypoxia does not stimulate
AMPK activation in RCC cells (data not shown). Together, this
may explain why normal epithelial cells reduce interleukin
expression under hypoxic conditions in contrast to RCC cells,
which do not exhibit the ability to inhibit interleukin expression
under hypoxic conditions. The mechanisms by which AMPK
activity are reduced and/or inactivated in RCC are under current
investigation. Importantly, however, we do find that pharmaco-
logical activation of AMPK in RCC cells using AICAR reduces
Nox4 expression and hypoxia-induced IL-6 and IL-8 production.
This is the first study demonstrating molecular suppression of pro-
inflammatory production by activation of the AMPK pathway.
Although we did not examine downstream mediators of Nox4
induced IL-6 and IL-8 production, we are currently examining the
role of the redox-sensitive transcription factor, NF-kB, which is
potent intracellular regulator of interleukin secretion. Reactive
oxygen species have been implicated as second messengers
involved in the activation of NF-kB as several studies have
demonstrated that activation of NF-kB by nearly all stimuli can be
blocked by antioxidants [28,29,30] and Nox4 inhibition [31].
Reactive oxygen species on NF-kB activation is further supported
by studies demonstrating that hydrogen peroxide induces NF-kB-
dependent interleukin-8 expression in endothelial cells, which
contributes to the angiogenic phenotype [32]. The role of Nox4-
dependent activation of NF-kB in response to hypoxia in RCC is
under current investigation.
The biological significance and clinical relevance of IL-6 and
IL-8 levels in RCC is presently unknown. We find that RCC cells
exposed to IL-6 and IL-8 enhanced cell invasion as measured
using a Boyden chamber. While IL-6 enhanced cell invasion, our
studies suggested that IL-8 may be a stronger inducer of cell
invasion. However, we find that hypoxia induces an approximate
5–8 fold increase in IL-6 and IL-8 production in RCC cells at
48 hours; suggesting that both interleukins play a role in RCC cell
invasion. The molecular aspects of cell invasion are complex and
involve multi-step processes requiring proteolysis of matrix
components and cell migration. The biological roles by which
individual IL-6 and IL-8 mediate these complex processes are
under current investigation. The role of Nox4-derived ROS in
mediating IL-6 and IL-8-dependent RCC cell invasion is
supported by our findings that pretreatment of RCC cells with
the antioxidant, NAC or the Nox inhibitor, DPI in addition to
specific Nox4 silencing with siRNA reduces IL-6 and IL-8
production and this conditioned media is unable to stimulate
RCC cell invasion when compared to hypoxia conditioned media.
Clinically relevant is the fact that the AMPK activator, AICAR,
which we show in this study to reduce Nox4 expression and IL-6
and IL-8 production, reduces RCC cell invasion in vitro and in ex
vivo RCC cells isolated from a human clear cell carcinoma tumor.
Our observations indicate that pharmacological activation of
AMPK and antioxidants targeting Nox4 may represent a relevant
therapeutic intervention to reduce IL-6- and IL-8-induced
inflammation and cell invasion in RCC.
Supporting Information
Figure S1 Effects of hypoxia on the production of
inflammatory markers in RCC 786-O cells. A) CD40-L
B) INF-gamma C) Interleukin-1A D) Interleukin-1B E) Interleu-
kin-17 and F) TNF-alpha secretion by RCC 786-O exposed to
normoxic (norm) or hypoxic conditions for short (T15-180min) or
long (T24-T72hr) time points was determined by mosaic ELISA as
outlined in materials and methods.
(TIF)
Figure S2 Effects of hypoxia on the production of
inflammatory markers in RCC4 cells. A) CD40-L B) INF-
gamma C) Interleukin-1A D) Interleukin-1B E) Interleukin-17 and
F) TNF-alpha secretion by RCC 786-O exposed to normoxic
(norm) or hypoxic conditions for short (T15-180min) or long (T24-
T72hr) time points was determined by mosaic ELISA as outlined
in materials and methods.
(TIF)
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